Company news
Sunshine Biopharma Inc. news in 2023
Sunshine Biopharma Inc.'s news releases, calls and decks from 2023, newest first.
Sunshine Biopharma Moves Principal Office to New York City
December 3, 2023
Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition
November 12, 2023
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
August 10, 2023
Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market
May 15, 2023
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
May 11, 2023
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
May 10, 2023
Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update
April 4, 2023
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment
February 27, 2023
Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound
February 9, 2023
Sunshine Biopharma Announces Share Repurchase Program
January 18, 2023